Logo
x

Search

Subscribe Now

ProQR

ProQR’s Sepofarsen Failed to Meet its Primary Endpoint in P-II/III Illuminate Study for CEP290-mediated LCA10

ProQR’s Sepofarsen Failed to Meet its Primary Endpoint in P-II/III Illuminate Study for CEP290-mediated LCA10

  • February 14, 2022
PharmaShots Interview: Dr. Robert Koenekoop Shares Insights on Stellar Study Evaluating ProQR's QR-421a

PharmaShots Interview: Dr. Robert Koenekoop Shares Insights on Stellar Study Evaluating ProQR's QR-421a

  • May 3, 2021
PharmaShots Weekly Snapshots (Mar 22 - 26, 2021)

PharmaShots Weekly Snapshots (Mar 22 - 26, 2021)

  • March 26, 2021
PharmaShots Interview: ProQR's Daniel A. de Boer Shares Insight on Sepofarsen, the First Treatment for Leber Congenital Amaurosis 10 (LCA10)

PharmaShots Interview: ProQR's Daniel A. de Boer Shares Insight on Sepofarsen, the First Treatment for Leber Congenital Amaurosis...

  • March 8, 2021
PharmaShots Weekly Snapshot (January 27-31, 2020)

PharmaShots Weekly Snapshot (January 27-31, 2020)

  • February 3, 2020
PharmaShots Weekly Snapshot (October 14-18, 2019)

PharmaShots Weekly Snapshot (October 14-18, 2019)

  • October 21, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.